viernes, 20 de noviembre de 2026
Continuing advanced therapies before surgery linked to fewer Crohn's complications
https://www.news-medical.net/news/20261119/Continuing-advanced-therapies-before-surgery-linked-to-fewer-Crohns-complications.aspx
Patients with Crohn's disease who continue advanced therapies, including biologics and small-molecule drugs, in the months before elective colorectal surgery may have a lower risk of two postoperative complications: anastomotic leak and organ space surgical site infection, according to a study published in the Journal of the American College of Surgeons.
These findings challenge previous thoughts that immunosuppressive therapies should be stopped before surgery due to concerns about postoperative complications. In contrast, advanced therapy use was associated with improved outcomes and lower risk of anastomotic leak and organ space surgical site infection, a feared complication of colorectal surgery.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario